MyHomeDoc, an Israeli startup developing a remote diagnostic device, has received FDA approval for its telehealth solution. The FDA’s OK follows quickly after receiving CE marketing clearance in Europe, now opening the company to the coveted healthcare market in the United States.
Support from Phillips and Teva
The device developed by MyHomeDoc relies on 4 built-in sensors that connect to the user’s smartphone to provide instant remote vital sign readings, performing the nine most common tests required for primary medical care. The 9 tests include a stethoscope check (lung, heart and bowel sounds), ear otoscopy, oximeter (pulse rate and saturation), thermometer (body temperature), and throat and skin test who uses the smartphone camera. The MyHomeDoc allows patients from anywhere at any time to send vital signs readings directly to the user’s attending physician, who can prioritize their exams accordingly.
In addition, the device, which can be used on children as young as two years old, also helps reduce frequent visits to the clinic for the elderly, patients with pre-existing conditions, chronic pain or others, becoming even more prevalent during the social distancing pandemic. Users are treated with an easy-to-use interface where they can receive their physician’s advice, recommendation or prescription in real time.
MyHomeDocument was founded in 2016. The product originated after receiving support from a joint venture platform, comprising Phillips, Teva and Sanara Ventures. The company has offices in New York and a headquarters in Israel.
“An FDA approval is an important milestone for every startup in the healthcare industry. This will help us harness technology that advances telemedicine with a solution that helps both patients and medical staff. The COVID-19 pandemic has illustrated the acute need for telemedicine solutions that simplify clinical testing and the diagnostic process at the patient’s home or at community health centers. We are confident that integrating our cutting edge healthcare technology will pave the way for more benefits for patients and providers, ”said Alon Natanson, CEO of MyHomeDoc.